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We have evaluated urinary monitoring and erythrocyte analysis to determine Mg absorption in human subjects as alternatives to the con-
ventional technique of faecal monitoring by stable-isotope techniques. Ten healthy adults received 2·2 mmol 25Mg in water, together with
wheat bread, followed 15 min later by intravenous injection of 0·6 mmol 26Mg (day 1). Brilliant blue and Yb (given on day 0 and day 1
respectively) served as qualitative and quantitative faecal markers. Urine was collected for 6 d after test meal intake. Complete collections
of faeces were made until excretion of the second brilliant blue marker (given on day 7). Mg isotope ratios were determined by thermal
ionisation-MS in urine and faeces and by inductively coupled plasma-MS in erythrocytes. Absorption was determined based on: (1) 6 d
urine pools; (2) 24 h urine pools (collected 22–46 h after test meal intake); (3) erythrocytes from a blood sample drawn on day 14; (4)
complete 6 d faecal pools; (5) faecal pools based on the first three consecutive stools after excretion of the first brilliant blue marker.
Differences in mean Mg absorption (42 44 %) were statistically insignificant between techniques, except when based on 6 d urine pools
for which the value was significantly lower (33 (SD 7) %, P¼0·0003, ANOVA). The results indicate that Mg absorption can be determined
from 24 h urine pools or erythrocytes obtained 14 d after test meal intake, an alternative method to the more time-consuming and labour-
intense faecal monitoring. The choice of technique depends on practical and financial considerations.
Magnesium absorption: Stable isotopes: Faecal monitoring: Urinary monitoring: Erythrocytes
Inadequate intake of Mg and low serum Mg levels have
been discussed in relation to major public health problems
such as osteoporosis (Abraham, 1991), coronary artery
disease (Karppanen, 1981) and non-insulin-dependent dia-
betes mellitus (Kao et al. 1999). Although information
about dietary intake of Mg is available in many industrial-
ised countries, very little is known about Mg bioavailabil-
ity and the influence of diet composition on Mg absorption.
The lack of information is at least partly due to the lack of
suitable methodologies to investigate Mg metabolism in
human subjects. The chemical-balance technique is not a
useful tool, as absorption from single meals cannot be
determined; although radioactive isotopes have been
shown to be useful to study the absorption of minerals
such as Ca (DeGrazia et al. 1965) and Zn (Arvidsson
et al. 1978), Mg radioisotopes have half-lives that are too
short (,21·3 h) to be useful.
Stable-isotopes techniques, however, can be used as Mg
has three stable isotopes, two of them with low enough
natural abundances to be employed as enriched labels:
25Mg and 26Mg (10·0 and 11·0 % natural abundance
respectively; Catanzaro, 1966). The technique most often
used to determine Mg absorption is based on faecal
monitoring of non-absorbed stable isotope label. This
technique has been applied to measure Mg absorption in
human subjects in several studies (Schwartz et al. 1978,
1984; Schuette et al. 1993; Tahiri et al. 2001; Sabatier
et al. 2003). A second isotope label can be injected intra-
venously so as to estimate the absorbed and re-excreted
isotope label during the faecal collection period. By cor-
recting apparent absorption (AA) of Mg via excretion of
the intravenous label in faeces, true absorption (TA) of
Mg as the fraction of isotopic label absorbed by the
intestine can be calculated. A major drawback of faecal
monitoring, however, is the need for complete faecal
collections over several consecutive days. Non-absorbable
rare earth elements as quantitative faecal markers have
therefore been introduced, allowing the possibility
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of a reduced collection period (Schuette et al. 1993;
Fairweather-Tait et al. 1997).
Urinary monitoring of an oral administered Mg isotopic
label and a second intravenously injected Mg isotopic label
was been introduced by Schwartz and colleagues as an
alternative technique to determine the TA of Mg in
human subjects (Schwartz et al. 1978, 1984). The first
applications were limited by the precision in isotopic anal-
ysis achievable by neutron activation analysis and GC–
MS. With the wider availability of thermal ionisation MS
and inductively coupled plasma (ICP)-MS for high-pre-
cision Mg isotope-ratio measurements, urinary monitoring
has been shown recently to be a potentially useful tech-
nique (Abrams & Wen, 1999; Sabatier et al. 2003).
Techniques based on erythrocyte incorporation of iso-
tope labels are routinely used to measure the TA of Fe
either with radioisotope labels (Cook et al. 1972) or
stable isotope labels (Kastenmayer et al. 1994), as most
of newly absorbed Fe is incorporated into this tissue.
Although erythrocytes are not a specific target tissue for
Mg, their Mg concentration is relatively high, approxi-
mately 2·5 mmol/l (Durlach, 1988). Coudray et al. (1997)
reported erythrocyte analysis after administration of
stable Mg isotope labels to be a useful method to determine
Mg absorption in rats.
The aim of the present study was to compare the TA of
Mg in healthy adult human subjects as determined by
different Mg double-stable-isotope techniques. Measure-
ments were based on isotope ratios in 6 d and 24 h urine
pools and erythrocytes after oral and intravenous adminis-
tration of two different isotope labels (25Mg and 26Mg).
Faecal monitoring as the established technique to assess
the TA of Mg in human subjects has been chosen as the
reference technique for comparison. TA has been deter-
mined by faecal monitoring based on 6 d pools as the con-
ventional approach and based on three-stool pools
corrected for the recovery of Yb (a non-absorbable faecal
marker) to evaluate whether the stool collection period
can be shortened.
Materials and methods
Subjects
Ten apparently healthy, free-living subjects (five men, five
women; BMI 21·2 (SD 3·7) kg/m2, age 35·0 (SD 10·0) years)
were recruited for the study. No lactating or pregnant
women were included and no medication was allowed,
except for oral contraceptives. Intake of mineral and/or
vitamin supplements was not permitted 2 weeks before
and during the study. The subjects were informed orally
and in written form about the aims and the procedures of
the study and written informed consent was obtained.
The study protocol was reviewed and approved by the
Ethical Committee of the Swiss Federal Institute of Tech-
nology, Zurich.
Isotope labels
Highly enriched 25MgO (24Mg 1·04 (SD 0·01), 25Mg 98·73
(SD 0·01), 26Mg 0·23 (SD 0·01) %) and 26MgO (24Mg 0·39
(SD 0·01), 25Mg 0·11 (SD 0·01), 26Mg 99·51 (SD 0·01) %)
were purchased from Chemgas, Paris, France. 25MgO
(29·3 mmol) was dissolved in 2·5 ml 4 M-HCl and diluted
to 100 ml with water to be served as an orally ingested
label. The pH of the solution was adjusted to 4–5 by
addition of an aqueous NaHCO3 (Merck, Darmstadt,
Germany) solution.
Doses for intravenous administration were prepared at
the Cantonal Pharmacy, Zurich, Switzerland. Sterile
water and sterile materials were used for their preparation.
26MgO (9·5 mmol) was dissolved in 2·5 ml 4 M-HCl,
diluted with water to 50 ml and adjusted to pH 6 as
described earlier. The sterile filtered solution was divided
into individual doses of 3·2 ml (about 0·6 mmol 26Mg),
transferred into glass vials, capped and sealed. The Mg
concentration of the 25Mg and 26Mg isotope label in sol-
ution was determined by isotope dilution using thermal
ionisation-MS against a commercial Mg standard of natural
isotopic composition (Titrisol; Merck).
Unless otherwise noted, all chemicals were of analytical
grade, and all acids were further purified by surface
distillation. Only 18 MV water (Milli Q water system;
Millipore, Zurich, Switzerland) was used for laboratory
work and test meal preparation.
Test meal
The standardised breakfast consisted of wheat bread rolls,
prepared from 75 g white flour, using a standard recipe.
A relatively long fermentation (5 h) was used to degrade
phytic acid, a potential inhibitor of Mg absorption. Bread
rolls were prepared in bulk and stored frozen. Water
(200 g) was served as a drink, to which 2·20 (range
2·03–2·31) mmol 25Mg and 25·4 (range 25·3–26·5) mmol
Yb (as YbCl3.6H2O; Aldrich, Buchs, Switzerland) were
added in solution. The amount of ingested isotope labels
and Yb was determined by weighing.
Study design
Urine and faecal spot samples were collected on the day
before the test meal administration to determine baseline
Mg isotopic ratios. A gelatine capsule containing about
100 mg brilliant blue (Warner Jenkinson Europe, King’s
Lynn, Norfolk, UK) was administered orally to mark the
start of the faecal collection period. Venous blood samples
(10 ml) were drawn into heparinised glass tubes (Vacutai-
ner Systems, Plymouth, Devon, UK) for plasma Mg anal-
ysis. The test meal was served after an overnight fast.
Subjects were instructed to eat half of the bread before
drinking the labelled water in order to slow down gastroin-
testinal passage of the isotope label. Fifteen minutes after
test meal intake, 0·60 (range 0·57–0·65) mmol 26Mg was
administered intravenously. A sterile injection system con-
sisting of a two-way catheter and a septum injection port
was used. The isotope label solution was transferred quan-
titatively by flushing the system with physiological saline
(10 ml, 9 g NaCl/l). The amount of injected isotope label
was determined by weighing the syringe before and after
injection. No food or drink was allowed for 3 h following
breakfast. Standardised meals were provided for lunch
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(lasagne) and dinner (pizza) on day 1. Water (2 litres) was
provided as the only beverage for day 1. No additional
food was allowed on day 1. From day 2 onwards, diet
was unrestricted. To standardise faecal collection, a
second brilliant blue capsule (Warner Jenkinson Europe)
was administered on day 7 to mark the endpoint of the
faecal collection period. All stool samples were collected
separately, starting immediately after test meal adminis-
tration. Faeces were collected until the second brilliant
blue marker appeared. Urine was collected in parallel in
24 h pools until the end of day 6. On day 14, a venous
blood sample (10 ml) was drawn into a heparinised glass
tube for Mg isotopic analysis of erythrocytes. Plasma
was not analysed for its isotopic composition, as kinetic
studies suggested a relatively low half-life of Mg in
plasma, and therefore an isotopic enrichment too low for
isotopic analysis at day 14 (Avioli & Berman, 1966; Feil-
let-Coudray et al. 2002).
Urine, stool and blood sampling
Urine samples were collected in pre-weighed polyethylene
containers (Semadeni, Ostermundingen, Switzerland).
Each 24 h pool was weighed, a 50 g portion was removed
and acidified with 0·5 g 10 M-HCl before storage
(–258C). Urine pools (6 d) were prepared by combining
1 % of each 24 h pool by weight.
Stools were collected in pre-weighed polypropylene con-
tainers (Semadeni), freeze-dried (Modulyo, Edwards,
North Bergen, NJ, USA), weighed and ground in a
mortar. Two stool pools were prepared:
(1) 6 d stool pools: all stools collected from the appear-
ance of the first brilliant blue marker until, but not
including the stool dyed by the second brilliant blue
marker (given on day 7). For preparation of the
pools, 5 % of each stool were taken by weight, com-
bined and thoroughly mixed.
(2) three-stool pools: the first three consecutive stools
after the appearance of the first brilliant blue marker,
including the first dyed stool, were pooled by
combining 5 % of each stool by weight.
Venous blood samples (10 ml) were centrifuged at 208C at
500 g (Omnifuge 2.0 RS; Heraeus, Zurich, Switzerland) to
separate plasma from blood cells. Blood cell fractions were
washed three times with small portions (2–3 ml) of physio-
logical saline (9 g NaCl/l). Washed blood cell fractions,
containing almost exclusively erythrocytes, were stored in
acid-washed polyethylene vials (–258C) for later analysis.
Sample digestion
Freeze-dried bread (1 g), acidified urine (3 ml), blood
plasma (1 ml) and erythrocytes (1 ml) were digested with
a mixture of 14 M-HNO3 and 8·8 M-H2O2 (Merck), using
a microwave (MLS 1200; MLS GmbH, Leutkirch,
Germany). Faecal samples were dry-ashed in covered
Pyrex glass beakers in a muffle furnace (M 110; Heraeus)
at 5508C for 12 h after addition of 5 ml 14 M-HNO3.
The ashes were dissolved in 10 ml 5 M-HCl. Beakers
were discarded after use.
Sample preparation for isotopic analysis
All samples were analysed in duplicate. Mg was
separated from the digested samples by cation-exchange
chromatography using a strongly acidic ion-exchange resin
(AG 50W X-8, 200–400 mesh; Bio-Rad, Hercules, CA,
USA). Portions of the digested stool, urine and erythrocyte
samples, containing approximately 8·2mmol (faecal
samples) or 2·5mmol (urinary and erythrocyte samples)
Mg, were evaporated to dryness and redissolved in 1 ml 0·7
M-HCl and transferred onto the top of a column (Bio-Rad,
10 mm inner diameter), filled with the ion-exchange resin
to a height of 70 mm. The column was rinsed with 56 ml
0·7 M-HCl, followed by 24 ml 0·9 M-HCl to elute Na and
K. Mg was eluted with 12 ml 1·4 M-HCl. The solution was
evaporated to dryness and redissolved in 50ml water. Mg
recovery was evaluated with a diluted Mg standard solution
(Titrisol; Merck). At a recovery of 94·8 (SD 1·8) % (n 10),
potential Mg isotopic fractionation on the column as a poss-
ible source of systematic bias is negligible. Resins were
regenerated with 30 ml 6 M-HCl and renewed after the fifth
run. Isotopic and elemental analysis was performed under
blank control. Only acid-washed Teflon and polyethylene
laboratory ware was used for sample processing. Portions
of the 26Mg isotope label were processed in parallel with
each batch for blank monitoring from ion-exchange chroma-
tography onwards. Sample contamination due to natural Mg
was found to be 10·3 (SD 4·1) nmol (n 6) for combined sample
preparation and filament loading, which was ,0·5 % of the
Mg separated.
Isotopic analysis by thermal ionisation-MS
Faecal and urine samples were analysed for isotopic com-
position by loading about 20 nmol separated Mg onto the
metal surface of the evaporation filament of a double-Re
filament ion source. Mg was coated with 5–10mg silicagel
100, 0·8mmol boric acid and 30 nmol Al as AlCl3 (all
chemicals from Merck). Compounds were loaded in aqu-
eous solution and dried at 0·8 A after each step. Finally,
the evaporation filament was heated to dull red heat (1·6
A) for 30 s. The ionisation filament remained unloaded.
Isotopic ratios were determined with a single-focusing
magnetic sector field instrument (MAT 262; Finnigan
MAT, Bremen, Germany), equipped with a Faraday cup
multicollector device for simultaneous ion-beam detection.
The evaporation filament was heated to 12308C using a
standardised procedure. The ionisation filament was
heated gradually to 1250–13508C until a stable Mgþ ion
beam of 1–2 £ 10211A was obtained. Each measurement
consisted of thirty consecutive isotopic ratio measurements.
Reproducibility (five independent runs) was 0·2 % (rela-
tive SD) for the 24Mg:25Mg isotopic ratio and 0·4 % (relative
SD) for the 24Mg:26Mg isotopic ratio.
Isotopic analysis by inductively coupled plasma-MS
Isotopic enrichment of erythrocytes was found to be too
low for isotopic analysis by thermal ionisation-MS.
Erythrocyte Mg was, therefore, analysed by multicollector
ICP-MS at higher precision. All ICP-MS measurements
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were carried out using a magnetic sector ICP-MS
(IsoProbe; Micromass, Manchester, UK) equipped with a
multi-collector system of nine Faraday cups. The sample
introduction system consisted of a Micromist nebuliser
and a Cinnabar spray chamber (both Glass Expansion,
Romainmotier, Switzerland). The instrument utilises a
hexapole collision cell for collisional focusing and interfer-
ence reduction. The collision gases were H (1·0 ml/min)
and He (7·5 ml/min).
Further studies using the high-resolution mode of the
instrument revealed a small interference at mass 26 due
to the formation of atomic or molecular ions in the ion
source. This interference remained stable even with NaCl
(100mg/g) added to the measurement solution. No matrix
effects on the measured isotopic ratios were observed.
The interference on mass 26 was therefore corrected by
the external blank subtraction.
The measurement sequence for each enriched sample
was: NBS980 (standard reference material 980; National
Institute of Standards and Technology, Gaithersburg,
MD, USA), baseline sample, enriched sample, baseline
sample and finally again NBS980. Drifts in mass discrimi-
nation were corrected by assuming a linear drift between
the two measurements of the isotope reference material.
Reproducibility (six independent runs) was 0·01 % (relative
SD) for the 24Mg:25Mg isotopic ratio and 0·02 % (relative
SD) for the 24Mg:26Mg isotopic ratio. More details about
the ICP-MS procedure applied can be obtained from
Klingbeil et al. (2001).
Magnesium and ytterbium
Total Mg content of stool pools, plasma and bread rolls
was determined after dilution of the digested samples by
flame atomic absorption spectroscopy (SpectrAA 400;
Varian, Mulgrave, Victoria, Australia) using standard pro-
cedures. A commercial Mg standard (Titrisol; Merck) was
used for internal calibration (standard addition technique)
to minimise matrix effects. Certified reference materials
(Wheat Flour 1567a, National Bureau of Standards,
Gaithersburg, MD, USA; Seronorm Trace Elements
Serum, Nycomed, Oslo, Norway) were analysed in parallel
for quality control. Yb was measured in the digested and
diluted faecal samples by electrothermal atomic absorption
spectroscopy, using an external calibration technique
against a Yb standard solution (Titrisol; Merck).
Calculations
Mg absorption was calculated by five different techniques
based on the molar amounts of the 25Mg and 26Mg isotope
label in the samples, which were calculated based on
double-isotope dilution principles (Walczyk et al. 1997;
Sabatier et al. 2002). Molar amounts of isotope labels
were calculated from measured isotope ratios, as the
stable isotope labels used were not mono-isotopic. The
ratio of the molar amounts of both isotope labels in the
sample is referred to as their molar amount ratio in the fol-
lowing. Techniques involving quantification of both iso-
tope labels (urinary monitoring, erythrocyte analysis and
faecal monitoring after correction for re-excreted isotopic
label) give the TA of Mg as the amount of oral isotope
label absorbed by the intestine. Faecal monitoring based
solely on the recovery of the oral isotope label in faeces
delivers the AA of Mg. The AA of Mg is generally
lower than the TA, as it does not take into account the
fraction of oral isotope label that has been absorbed and
re-excreted into faeces during the faecal collection time.
Technique 1: true absorption via urinary monitoring of
both isotope labels. TA (% oral isotope label) was
calculated from the molar amount ratio of oral and intrave-
nous isotope label n25:n26 in 6 d pools (technique 1a) and
24 h pools collected 22–46 h after test meal intake (tech-
nique 1b) respectively:
TA ð%Þ ¼ n25
n26
£ Div
D0
£ 100; ð1Þ
where Div is the amount isotope label injected (mmol) and
D0 the amount oral isotope label ingested (mmol).
Technique 2: true absorption measured via isotopic
analysis of erythrocytes. TA of the oral isotope label
(%) was calculated from the molar amount oral:intravenous
isotope label ratio in erythrocytes drawn 14 d after isotope
label administration. Calculations followed equation 1
using the amount ratio of both isotope labels n25:n26 in
erythrocytes instead of those in urine.
Technique 3: apparent absorption via recovery of oral
isotope label. AA (%) was calculated as the difference
between the amount of oral isotope label given (D0) and
the amount excreted in faeces (F0) in mmol for the 6 d
faecal pools assuming a complete recovery of non-
absorbed oral isotope label (technique 3a).
AA ð%Þ ¼ 100 £ D0 2 F0
D0
: ð2Þ
For a shortened faecal collection period (technique 3b),
apparent Mg absorption was calculated using equation 3.
Calculations were based on the first three consecutive
stools after appearance of the first brilliant blue marker,
including the first dyed stool. Incomplete recovery of
the oral isotope label was corrected for by using the
fraction of rare earth element recovered in faeces
(% REE):
AA ð%Þ ¼ 100 £ 12 D0 2 F0
D0
 
£ 100
% REE
: ð3Þ
Technique 4: true absorption via faecal monitoring of
oral and intravenous isotope label. TA (%) was derived
from AA by correction for the molar amount of oral
isotope label that was absorbed and excreted within the
faecal collection period. The molar amount of intravenous
label (Fiv) recovered in the 6 d pools was used for
correction (technique 4a).
TA ð%Þ ¼ 100 £ ðD0 2 F0Þ=D0
12 Fiv=Div
 
: ð4Þ
For a shortened faecal collection period covering three
consecutive stools including the first dyed stool (technique
4b), incomplete recovery of the oral label was corrected via
the recovery of the administered rare earth element in the
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faecal pool as described for technique 3b.
TA ð%Þ ¼ 100 £ ðD0 2 F0Þ=D0
12 Fiv=Div
 
£ 100
% REE
: ð5Þ
Statistics
Calculations were performed using commercial spread-
sheet software (Excel 97, Microsoft and SPSS 10.0;
SPSS Inc., Chicago, IL, USA). ANOVA was made using
a general linear model, followed by either a Bonferroni
test or Student’s paired two-tailed t test to determine differ-
ences between methods. Statistical significance was con-
sidered for P,0·05. Correlation between methods was
evaluated by Pearson correlation coefficients. Normal
distribution of absorption values was verified by skewness
and the Kolmogorov–Smirnoff test. Homogeneity of
variance between the methods was verified with Levene’s
test. Absorption values are presented as arithmetic means
and standard deviations.
Results
One subject was excluded from the three-stool pool
evaluation due to gastrointestinal problems, and one
subject was excluded from the double-isotope evaluations
due to incomplete intravenous injection. Plasma concen-
trations of Mg were 1·02 (range 0·92–1·22) (SD 0·09)
mmol/l (n 10; reported normal range 0·75–0·96 mmol/l;
Lowenstein & Stanton, 1986). The native Mg content of
the wheat bread was 1·91 mmol per serving.
Mean Mg absorption from the wheat bread consumed
with water varied from 32·9 to 44·2 % (Table 1) based on
the different techniques. AA values differed significantly
from TA values (6 d stool pools P¼0·001, three-stool
pools P¼0·01). TA based on the 6 d urine pools was sig-
nificantly lower than TA calculated using the other tech-
niques (P¼0·0003, ANOVA). There were no significant
differences between TA values based on the 24 h urine
pools (22–46 h), erythrocyte analysis and the 6 d faecal
pools or three-stool pools.
Brilliant blue appeared in faeces on day 1 or 2 in all sub-
jects. Completeness of faecal collection was evaluated by
the recovery of Yb; 98·7 (range 91·3–107·9) (SD 5·6) %
(n 10) was recovered in the 6 d stool pools. Mean duration
of faeces collection using brilliant blue for marking the
beginning and end of faeces collection was 6·3 (range
5–7) (SD 0·7) d for the 6 d faecal pools. Excretion of the
25Mg label and of Yb measured in the three-stool pools
were significantly correlated (Fig. 1; P,0·01). Yb
recovery in the three-stool pools, excreted within 3·0
(SD 0·9) d after intake of the isotope labels, was 80·5
(range 55·2–101·0) (SD 18·5) % (n 9). AA and TA deter-
mined by faecal monitoring based on the 6 d stool pools
and the three-stool pools were significantly correlated
(AA r 0·76, P,0·05; TA r 0·83, P,0·05) as was TA
based on 6 d and 24 h urine pools (r 0·73, P,0·05). Mg
absorption based on erythrocyte analysis was significantly
correlated only to absorption based on the 24 h urine
pools (r 0·78, P,0·05).
A difference in isotopic composition between erythro-
cytes and Mg of non-biological origin was observed. Base-
line Mg isotopic ratios in erythrocytes of ten subjects were
greater by 2·1 (SD 0·3) and 3·6 (SD 0·8) ‰ (25Mg:24Mg and
26Mg:24Mg respectively) than the certified isotope
Table 1. Fractional magnesium absorption (%) based on different stable isotope techniques*†
Method. . . Urinary monitoring Erythrocyte analysis Faecal monitoring
Information. . . True absorption True absorption Apparent absorption True absorption
Sample. . . 6 d pool 24 h pool day 14 6 d pool three stool pool 6 d pool three stool pool
Technique. . . 1a 1b‡ 2 3a 3b 4a 4b
Subject 1 26·2 37·9 34·7 39·7 34·2 51·1 42·8
Subject 2 43·8 50·0 51·4 52·7 47·1 63·6 52·8
Subject 3 43·3 55·5 49·4 44·4 43·8 47·8 50·1
Subject 4 28·3 34·0 38·8 36·3 36·0 40·5 37·2
Subject 5 24·5 45·0 45·8 29·9 36·7 32·4 39·0
Subject 6 35·2 51·2 48·7 36·9 41·0 48·5 41·6
Subject 7 29·9 39·0 30·0 32·5 39·3 38·9 40·2
Subject 8 ND ND ND 30·1 29·2 ND ND
Subject 9 33·4 39·1 44·9 38·1 ND 48·8 ND
Subject 10 31·8 36·9 37·9 22·8 34·3 25·7 36·7
Mean 32·9a 43·2b 42·4b 36·3c 38·0c 44·2b 42·6b
SD of mean 6·9 7·6 7·4 8·4 5·5 11·2 5·9
D(24Mg : 25Mg)§ 5·6 6·4 1·7 15·2 28·2 15·2 28·2
SD of mean 1·0 1·1 0·2 3·1 12·4 3·1 3·1
D(24Mg : 26Mg)§ 4·4 3·9 1·0 0·8 0·9 0·8 0·9
SD of mean 0·5 0·5 0·2 0·5 0·5 0·5 0·5
ND, not determined.
a,b,c Mean absorption values within a row with unlike superscript letters were significantly different (P ,0·05).
* For details of procedures, see p. 116.
† Isotope ratio measurements were determined by thermal ionisation-MS in urine and faeces and by inductively coupled plasma–MS in
erythrocytes obtained 14 d after isotope administration.
‡ Based on urine collected 22–46 h after test meal intake.
§ Mean isotopic enrichments (%) over baseline values in the sample material are given for the 24Mg:25Mg [D(24Mg:25Mg)] and the 24Mg:26Mg
[D(24Mg:26Mg)] isotope ratio, respectively.
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reference material (NBS980; standard reference material
980; National Institute of Standards and Technology)
(P¼0·00001, n 10).
Discussion
Our present results demonstrate for the first time that the
molar amount ratio of orally ingested and intravenously
administered Mg stable isotope labels in erythrocytes
(technique 2) is a potentially useful technique to determine
the TA of Mg in human subjects (see Table 1). The same is
given for the urinary monitoring technique based on 24 h
urine pools collected 22–46 h after test meal adminis-
tration (technique 1b). For either technique, the TA of
Mg from the test meal was not significantly different
when compared with results obtained by the conventional
double-isotope faecal-monitoring method (technique 4a).
In addition, we have shown that the shorter three-stool
pool method, corrected for incomplete faecal collections
by excretion of Yb (techniques 3b and 4b), resulted in
similar Mg absorption results as the 6 d faecal-monitoring
method (techniques 3a and 4a respectively). It appears,
therefore, that any of the methods to determine the TA
of Mg will give similar results when used to monitor
dietary factors influencing Mg absorption, at least in a
healthy young study population. The only method that
resulted in a significantly lower TA relative to faecal moni-
toring was that based on the 6 d urine pools. As expected,
TA (techniques 4a and 4b respectively) was significantly
higher than AA (technique 3a and 3b respectively).
Erythrocytes are easily accessible and, without the need
for complete faecal or urine collections, erythrocyte anal-
ysis of isotope labels would greatly reduce the time and
labour needed to determine Mg absorption. The method
assumes that, after absorption, the isotope label added as
an extrinsic tag to a meal is metabolised in an identical
way to an isotope label injected intravenously. Although
injecting the isotope label intravenously as a bolus
15 min after consumption of a simple test meal appeared
satisfactory in our present studies, the timing and duration
of the infusion needs further evaluation with more complex
meals. Fe absorption is routinely determined using erythro-
cyte incorporation of a single orally administered isotope
label, assuming a mean erythrocyte incorporation of 80 %
after 14 d (Cook et al. 1972). In our present studies,
about 1 % of the absorbed oral dose was recovered in
erythrocytes. Although further studies are needed to
validate erythrocyte analysis as a method for determination
of Mg absorption, this approach is supported by an earlier
study in rats: there was no significant difference in absorp-
tion based on erythrocytes, plasma and urine samples col-
lected 48 h (erythrocytes and plasma) or 36–48 h (urine)
after oral and intravenous isotope label administration
(Coudray et al. 1997). Isotopic analysis of erythrocytes,
however, is more demanding. Isotopic enrichments in
erythrocytes are significantly lower when compared with
faecal pools and require more precise isotope ratio
measurements to generate meaningful data.
Measurement of low isotopic enrichment in biological
samples might be associated with an additional methodo-
logical problem. Natural isotopic abundances of an element
can be altered, in principle, by physiological processes
(Galimov, 1985). Using thermal ionisation-MS, no such
effects were observed for Mg in faecal and urine baseline
samples relative to a Mg standard of non-biological
origin (Titrisol; Merck), but the more precise multicollec-
tor ICP-MS measurements revealed differences in Mg iso-
topic composition between erythrocytes and an isotope
reference material of non-biological origin. This problem
was overcome by measuring the enriched sample together
with the baseline sample for each subject.
TA was also determined in the present study based on
molar amounts of oral:intravenous isotope label ratio in
urine. TA of Mg based on 6 d urine pools was, however,
significantly lower (P,0·05) compared with all other tech-
niques of TA, including the 24 h urine pools (Table 1).
Recently Sabatier et al. (2003) reported a significantly
lower TA based on 3 d (days 1–3) urine pools compared
with 12 d faecal pools. It has been suggested that absorp-
tion is underestimated when based on urine collected
during the first hours after isotope label administration,
because oral and intravenous labels are metabolised differ-
ently and absorption of the oral isotope label might not yet
be complete (Abrams & Wen, 1999; Sabatier et al. 2003).
The inclusion of the first 24 h pools in our 6 d urine pools
could thus explain the lower absorption value generated by
the 6 d pools. In addition, a potential concern is the admin-
istration of the intravenous Mg label. Serum Mg levels are
strictly regulated by the kidney (Elin, 1994). Thus, if the
intravenous bolus results in a non-physiologically high
level of free Mg in the blood, excess Mg may be rapidly
excreted in urine, and the molar amounts of oral:injected
isotope label ratio in urine will underestimate absorption
in the first hours after isotope administration. To overcome
this problem, Coudray et al. (1997) suggested that the
intravenous dose should be infused over a long period of
time or divided into several smaller doses. Our present
findings indicate that a single intravenous bolus adminis-
tered 15 min after the oral isotope label is suitable to deter-
mine Mg absorption, provided that urine collection is
Fig. 1. Correlation between fractional excretion of the oral isotope
label (25Mg) and the quantitative faecal marker (ytterbium) in three-
stool pools (y ¼ 1·024x – 0·241; R 0·99, P,0·01). Values are
means for ten subjects.
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initiated later than about 22 h after isotope label adminis-
tration; this is in agreement with the findings of Sabatier
et al. (2003). It can be assumed that after about 22 h, TA
based on urinary monitoring of isotope labels corresponds
to TA as determined by the conventional faecal-monitoring
technique using an intravenous isotope label to correct for
re-excreted oral isotope label.
The conventional method for measuring Mg absorption
based on faecal monitoring of all non-absorbed isotope
labels is time consuming and laborious. To determine
TA by this technique, a second intravenous isotope
label is necessary to estimate the amount of absorbed
oral isotope label that is re-excreted during the faecal
collection period. This makes the method as invasive
and expensive as urinary monitoring or erythrocyte
analysis of isotope labels. For paired comparisons,
however, determination of AA of Mg by faecal monitor-
ing remains the only option. Because both isotope labels
are used for test meal labelling, no further isotope label
is available for intravenous administration. TA of Mg is
significantly underestimated by this method (Table 1),
but it is less invasive and cheaper than other techniques
as intravenous administration of a second isotope label is
not required.
A major technical problem with faecal monitoring is the
incomplete recovery of non-absorbed oral isotope label,
either due to incomplete faecal collection by the subjects
or due to prolonged gastrointestinal passage, resulting in
an overestimate of absorption. This source of error was
minimised in our present study by the use of brilliant
blue to determine the starting point and the endpoint of
the faecal collection period, and by using Yb as a non-
absorbable quantitative faecal marker for stool collection.
Our present results indicate that faecal collections could
be shortened from 6 d to three consecutive stools after
excretion of the first dose of brilliant blue by correcting
for incomplete recovery of isotope label using the rare
earth element Yb. In the three-stool pools, excretion of
the oral Mg isotope label and Yb was significantly
correlated (Fig. 1), and AA and TA determined by both
techniques did not differ significantly (Table 1, techniques
3a, 3b and 4a, 4b respectively). Gastrointestinal passage
time of the oral Mg isotope label and Yb were relatively
fast and the minimum recovery was 55 % in the three-stool
pools. Schuette et al. (1993) suggested that at least 40 % of
the rare earth element should be excreted in order to
correct for incomplete collection, using Dy as a faecal
marker to correct for Mg absorption. Although it can be
assumed that many of the rare earth elements exhibit
similar excretion patterns (Fairweather-Tait et al. 1997),
we chose Yb rather than Dy or Sm because it could be
detected with higher sensitivity by electrothermal-atomic
absorption spectroscopy. In order to apply a correction
by using a non-absorbable faecal marker, excretion pat-
terns of Mg and the rare earth elements have to be similar.
Based on the results from the present study, the shorter
stool collection technique is well suited for studies in
young healthy adults.
In conclusion, our present study showed that erythrocyte
analysis of stable isotope labels 14 d after administration of
an oral and an intravenous isotope label as well as
monitoring of both labels in urine collected 22–46 h
after isotope administration could be useful alternative
methods to the faecal-monitoring technique to determine
Mg absorption from food. If isotopic ratios can be
measured at high precision, erythrocyte analysis offers a
relatively simple technique avoiding faeces and urine col-
lections. In addition, in a young healthy study population,
6 d faecal monitoring can be shortened to three consecu-
tive stool pools by including Yb as a non-absorbable
faecal marker.
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